Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4337757)

Published in Stem Cells Int on February 09, 2015

Authors

Zhijing Liu1, Shi-Jiang Lu2, Yan Lu1, Xiaohua Tan3, Xiaowei Zhang1, Minlan Yang1, Fuming Zhang4, Yulin Li5, Chengshi Quan1

Author Affiliations

1: The Key Laboratory of Pathobiology, Ministry of Education, Department of Pathology, College of Basic Medical Sciences, Jilin University, 126 Xinmin Avenue, Changchun 130021, China.
2: Advanced Cell Technology, 33 Locke Drive, Marlborough, MA 01752, USA.
3: Key Laboratory of Biotechnology and Pharmaceutical Engineering, College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325000, China.
4: Morphology Center of Hematology Department, Cancer Center, the First Clinical Hospital of Jilin University, Changchun 130000, China.
5: The Key Laboratory of Pathobiology, Ministry of Education, Jilin University, 126 Xinmin Street, Changchun, Jilin 130021, China.

Articles cited by this

Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93

Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell (2008) 28.29

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52

In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21

Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35

An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell (2010) 5.00

Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90

Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A (1992) 4.28

The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol (2008) 3.56

Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) 3.48

Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells (2009) 3.46

Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem (1995) 3.22

PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood (2008) 3.21

Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01

Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin. Blood (2006) 1.95

Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods (2012) 1.91

The SCL gene product: a positive regulator of erythroid differentiation. EMBO J (1992) 1.90

Blood-forming potential of vascular endothelium in the human embryo. Development (2002) 1.87

Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica (2010) 1.79

Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood (2007) 1.76

Molecular insights into stress erythropoiesis. Curr Opin Hematol (2007) 1.70

Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol (2006) 1.61

Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol (2013) 1.61

Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell (2013) 1.42

Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol (1999) 1.28

Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev (2011) 1.25

Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS One (2011) 1.19

Hair follicle dermal cells repopulate the mouse haematopoietic system. J Cell Sci (2002) 1.18

Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica (2012) 1.09

Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells. Tissue Eng Part C Methods (2011) 1.09

Engineering a mimicry of bone marrow tissue ex vivo. J Biosci Bioeng (2005) 1.06

Molecular evidence for OCT4-induced plasticity in adult human fibroblasts required for direct cell fate conversion to lineage specific progenitors. Stem Cells (2014) 0.99

Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells. Stem Cell Reports (2013) 0.99

In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol (1991) 0.99

Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J (2007) 0.98

Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells. Stem Cells (2006) 0.95

Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood (1993) 0.93

CD34-positive cells: biology and clinical relevance. Haematologica (1995) 0.92

Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling. J Clin Invest (2013) 0.91

Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells. Tissue Eng Part C Methods (2011) 0.91

Induced pluripotent stem cells from human hair follicle mesenchymal stem cells. Stem Cell Rev (2013) 0.90

Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. Exp Hematol (2001) 0.90

Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One (2011) 0.88

Highly rapid and efficient conversion of human fibroblasts to keratinocyte-like cells. J Invest Dermatol (2013) 0.88

Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med (2008) 0.88

Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Bone Marrow Transplant (2005) 0.88

Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Stem Cells (2014) 0.83

Pluripotent stem cells in research and treatment of hemoglobinopathies. Cold Spring Harb Perspect Med (2012) 0.81

Direct conversion of human fibroblasts to functional neurons in one step. Neurosurgery (2011) 0.79

Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplant (2000) 0.78

Identification of hematopoietic cell populations from the dermal papillae of human hair follicles. Transplant Proc (2004) 0.77

Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J Hematother Stem Cell Res (1999) 0.76